193 related articles for article (PubMed ID: 31300453)
1. DNA Methylation Markers for Breast Cancer Detection in the Developing World.
Downs BM; Mercado-Rodriguez C; Cimino-Mathews A; Chen C; Yuan JP; Van Den Berg E; Cope LM; Schmitt F; Tse GM; Ali SZ; Meir-Levi D; Sood R; Li J; Richardson AL; Mosunjac MB; Rizzo M; Tulac S; Kocmond KJ; de Guzman T; Lai EW; Rhees B; Bates M; Wolff AC; Gabrielson E; Harvey SC; Umbricht CB; Visvanathan K; Fackler MJ; Sukumar S
Clin Cancer Res; 2019 Nov; 25(21):6357-6367. PubMed ID: 31300453
[TBL] [Abstract][Full Text] [Related]
2. Quantitative hypermethylation of a small panel of genes augments the diagnostic accuracy in fine-needle aspirate washings of breast lesions.
Jeronimo C; Monteiro P; Henrique R; Dinis-Ribeiro M; Costa I; Costa VL; Filipe L; Carvalho AL; Hoque MO; Pais I; Leal C; Teixeira MR; Sidransky D
Breast Cancer Res Treat; 2008 May; 109(1):27-34. PubMed ID: 17549626
[TBL] [Abstract][Full Text] [Related]
3. Detection of gene promoter hypermethylation in fine needle washings from breast lesions.
Jerónimo C; Costa I; Martins MC; Monteiro P; Lisboa S; Palmeira C; Henrique R; Teixeira MR; Lopes C
Clin Cancer Res; 2003 Aug; 9(9):3413-7. PubMed ID: 12960130
[TBL] [Abstract][Full Text] [Related]
4. Identification of breast cancer DNA methylation markers optimized for fine-needle aspiration samples.
Bu D; Lewis CM; Sarode V; Chen M; Ma X; Lazorwitz AM; Rao R; Leitch M; Moldrem A; Andrews V; Gazdar A; Euhus D
Cancer Epidemiol Biomarkers Prev; 2013 Dec; 22(12):2212-21. PubMed ID: 24089458
[TBL] [Abstract][Full Text] [Related]
5. High performance methylated DNA markers for detection of colon adenocarcinoma.
Klein Kranenbarg RAM; Vali AH; IJzermans JNM; Pisanic TR; Wang TH; Azad N; Sukumar S; Fackler MJ
Clin Epigenetics; 2021 Dec; 13(1):218. PubMed ID: 34903270
[TBL] [Abstract][Full Text] [Related]
6. High RASSF1A promoter methylation levels are predictive of poor prognosis in fine-needle aspirate washings of breast cancer lesions.
Martins AT; Monteiro P; Ramalho-Carvalho J; Costa VL; Dinis-Ribeiro M; Leal C; Henrique R; Jerónimo C
Breast Cancer Res Treat; 2011 Aug; 129(1):1-9. PubMed ID: 20842524
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation patterns of RAR-β2 and RASSF1A gene promoters in FNAB samples from Greek population with benign or malignant breast lesions.
Kougioumtsidou N; Vavoulidis E; Nasioutziki M; Symeonidou M; Pratilas GC; Mareti E; Petousis S; Chatzikyriakidou A; Grimbizis G; Theodoridis T; Miliaras D; Dinas K; Zepiridis L
Diagn Cytopathol; 2021 Jan; 49(1):153-164. PubMed ID: 32530576
[TBL] [Abstract][Full Text] [Related]
8. Detection of tumor markers including carcinoembryonic antigen, APC, and cyclin D2 in fine-needle aspiration fluid of breast.
Lee A; Kim Y; Han K; Kang CS; Jeon HM; Shim SI
Arch Pathol Lab Med; 2004 Nov; 128(11):1251-6. PubMed ID: 15508191
[TBL] [Abstract][Full Text] [Related]
9. Methylation profiling of benign and malignant breast lesions and its application to cytopathology.
Pu RT; Laitala LE; Alli PM; Fackler MJ; Sukumar S; Clark DP
Mod Pathol; 2003 Nov; 16(11):1095-101. PubMed ID: 14614048
[TBL] [Abstract][Full Text] [Related]
10. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer.
Uehiro N; Sato F; Pu F; Tanaka S; Kawashima M; Kawaguchi K; Sugimoto M; Saji S; Toi M
Breast Cancer Res; 2016 Dec; 18(1):129. PubMed ID: 27993161
[TBL] [Abstract][Full Text] [Related]
11. Quantitation of DNA Methylation by Quantitative Multiplex Methylation-Specific PCR (QM-MSP) Assay.
Fackler MJ; Sukumar S
Methods Mol Biol; 2018; 1708():473-496. PubMed ID: 29224159
[TBL] [Abstract][Full Text] [Related]
12. Quantitative multiplex methylation-specific PCR analysis doubles detection of tumor cells in breast ductal fluid.
Fackler MJ; Malone K; Zhang Z; Schilling E; Garrett-Mayer E; Swift-Scanlan T; Lange J; Nayar R; Davidson NE; Khan SA; Sukumar S
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3306-10. PubMed ID: 16740751
[TBL] [Abstract][Full Text] [Related]
13. Gene Methylation and Cytological Atypia in Random Fine-Needle Aspirates for Assessment of Breast Cancer Risk.
Stearns V; Fackler MJ; Hafeez S; Bujanda ZL; Chatterton RT; Jacobs LK; Khouri NF; Ivancic D; Kenney K; Shehata C; Jeter SC; Wolfman JA; Zalles CM; Huang P; Khan SA; Sukumar S
Cancer Prev Res (Phila); 2016 Aug; 9(8):673-682. PubMed ID: 27261491
[TBL] [Abstract][Full Text] [Related]
14. Molecular evaluation of a multiplex methylation panel for epigenetic analysis of FNAB samples from Greek patients with suspicious breast lesions.
Vavoulidis E; Petousis S; Margioula Siarkou C; Mareti E; Kougioumtsidou N; Symeonidou M; Loufopoulos PD; Daniilidis A; Chatzikyriakidou A; Lambropoulos A; Zepiridis L; Dinas K
J BUON; 2020; 25(5):2244-2254. PubMed ID: 33277842
[TBL] [Abstract][Full Text] [Related]
15. Validation of DNA promoter hypermethylation biomarkers in breast cancer--a short report.
de Groot JS; Pan X; Meeldijk J; van der Wall E; van Diest PJ; Moelans CB
Cell Oncol (Dordr); 2014 Aug; 37(4):297-303. PubMed ID: 25123395
[TBL] [Abstract][Full Text] [Related]
16. Methylated markers accurately distinguish primary central nervous system lymphomas (PCNSL) from other CNS tumors.
Downs BM; Ding W; Cope LM; Umbricht CB; Li W; He H; Ke X; Holdhoff M; Bettegowda C; Tao W; Sukumar S
Clin Epigenetics; 2021 May; 13(1):104. PubMed ID: 33952317
[TBL] [Abstract][Full Text] [Related]
17. Detection of Gastric Cancer with Novel Methylated DNA Markers: Discovery, Tissue Validation, and Pilot Testing in Plasma.
Anderson BW; Suh YS; Choi B; Lee HJ; Yab TC; Taylor WR; Dukek BA; Berger CK; Cao X; Foote PH; Devens ME; Boardman LA; Kisiel JB; Mahoney DW; Slettedahl SW; Allawi HT; Lidgard GP; Smyrk TC; Yang HK; Ahlquist DA
Clin Cancer Res; 2018 Nov; 24(22):5724-5734. PubMed ID: 29844130
[No Abstract] [Full Text] [Related]
18. Early detection of the major male cancer types in blood-based liquid biopsies using a DNA methylation panel.
Constâncio V; Nunes SP; Moreira-Barbosa C; Freitas R; Oliveira J; Pousa I; Oliveira J; Soares M; Dias CG; Dias T; Antunes L; Henrique R; Jerónimo C
Clin Epigenetics; 2019 Dec; 11(1):175. PubMed ID: 31791387
[TBL] [Abstract][Full Text] [Related]
19. Detection of aberrant methylation of a six-gene panel in serum DNA for diagnosis of breast cancer.
Shan M; Yin H; Li J; Li X; Wang D; Su Y; Niu M; Zhong Z; Wang J; Zhang X; Kang W; Pang D
Oncotarget; 2016 Apr; 7(14):18485-94. PubMed ID: 26918343
[TBL] [Abstract][Full Text] [Related]
20. Detection of 14-3-3 sigma (σ) promoter methylation as a noninvasive biomarker using blood samples for breast cancer diagnosis.
Ye M; Huang T; Ying Y; Li J; Yang P; Ni C; Zhou C; Chen S
Oncotarget; 2017 Feb; 8(6):9230-9242. PubMed ID: 27999208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
